218 related articles for article (PubMed ID: 17721936)
1. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release.
Lu Y; Yu Y; Tang X
J Pharm Sci; 2007 Dec; 96(12):3252-62. PubMed ID: 17721936
[TBL] [Abstract][Full Text] [Related]
2. [Rheological properties of sucrose acetate isobutyrate in situ gel].
Lu YX; He HB; Cui Y; Tang X
Yao Xue Xue Bao; 2007 Apr; 42(4):445-9. PubMed ID: 17633217
[TBL] [Abstract][Full Text] [Related]
3. Tracking the effect of microspheres size on the drug release from a microsphere/sucrose acetate isobutyrate (SAIB) hybrid depot in vitro and in vivo.
Lin X; Wang J; Xu Y; Tang X; Chen J; Zhang Y; Zhang Y; Yang Z
Drug Dev Ind Pharm; 2016 Sep; 42(9):1455-65. PubMed ID: 26790718
[TBL] [Abstract][Full Text] [Related]
4. In vivo evaluation of risperidone-SAIB in situ system as a sustained release delivery system in rats.
Lu Y; Tang X; Cui Y; Zhang Y; Qin F; Lu X
Eur J Pharm Biopharm; 2008 Feb; 68(2):422-9. PubMed ID: 17614267
[TBL] [Abstract][Full Text] [Related]
5. [Preparation and evaluation of risperidone-loaded microsphere/sucrose acetate isobutyrate in situ forming complex depot with double diffusion barriers].
Lin X; Tang X; Xu YH; Zhang Y; Zhang Y; He HB
Yao Xue Xue Bao; 2015 Jun; 50(6):775-82. PubMed ID: 26521452
[TBL] [Abstract][Full Text] [Related]
6. A Uniform Ultra-Small Microsphere/SAIB Hybrid Depot with Low Burst Release for Long-Term Continuous Drug Release.
Lin X; Xu Y; Tang X; Zhang Y; Chen J; Zhang Y; He H; Yang Z
Pharm Res; 2015 Nov; 32(11):3708-21. PubMed ID: 26077999
[TBL] [Abstract][Full Text] [Related]
7. A novel risperidone-loaded SAIB-PLGA mixture matrix depot with a reduced burst release: effects of solvents and PLGA on drug release behaviors in vitro/in vivo.
Lin X; Yang S; Gou J; Zhao M; Zhang Y; Qi N; He H; Cai C; Tang X; Guo P
J Mater Sci Mater Med; 2012 Feb; 23(2):443-55. PubMed ID: 22170300
[TBL] [Abstract][Full Text] [Related]
8. Delivery of radix ophiopogonis polysaccharide via sucrose acetateisobutyrate-based in situ forming systems alone or combined with itsmono-PEGylation.
Wang L; Zheng X; Wu F; Shen L; Lin X; Feng Y
Drug Deliv; 2018 Nov; 25(1):267-277. PubMed ID: 29334805
[TBL] [Abstract][Full Text] [Related]
9. Improvement of the Antitumor Efficacy of Intratumoral Administration of Cucurbitacin Poly(Lactic-co-Glycolic Acid) Microspheres Incorporated in In Situ-Forming Sucrose Acetate Isobutyrate Depots.
Wang JW; Xu JH; Li J; Zhao MH; Zhang HF; Liu DC; Zhou X; Xu H
J Pharm Sci; 2016 Jan; 105(1):205-11. PubMed ID: 26566075
[TBL] [Abstract][Full Text] [Related]
10. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
Kranz H; Bodmeier R
Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
[TBL] [Abstract][Full Text] [Related]
11. Microsphere delivery of Risperidone as an alternative to combination therapy.
D'Souza S; Faraj J; DeLuca P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
[TBL] [Abstract][Full Text] [Related]
12. Long acting porous microparticle for pulmonary protein delivery.
Kwon MJ; Bae JH; Kim JJ; Na K; Lee ES
Int J Pharm; 2007 Mar; 333(1-2):5-9. PubMed ID: 17296275
[TBL] [Abstract][Full Text] [Related]
13. Sucrose Acetate Isobutyrate as an In situ Forming Implant for Sustained Release of Local Anesthetics.
Li H; Xu Y; Tong Y; Dan Y; Zhou T; He J; Liu S; Zhu Y
Curr Drug Deliv; 2019; 16(4):331-340. PubMed ID: 30451111
[TBL] [Abstract][Full Text] [Related]
14. Injectable long-term control-released in situ gels of hydrochloric thiothixene for the treatment of schizophrenia: preparation, in vitro and in vivo evaluation.
Xin C; Lihong W; Qiuyuan L; Hongzhuo L
Int J Pharm; 2014 Jul; 469(1):23-30. PubMed ID: 24751344
[TBL] [Abstract][Full Text] [Related]
15. Collagen-chondroitin sulfate-based PLLA-SAIB-coated rhBMP-2 delivery system for bone repair.
Keskin DS; Tezcaner A; Korkusuz P; Korkusuz F; Hasirci V
Biomaterials; 2005 Jun; 26(18):4023-34. PubMed ID: 15626448
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable nanoparticles for protein delivery: analysis of preparation conditions on particle morphology and protein loading, activity and sustained release properties.
Coleman J; Lowman A
J Biomater Sci Polym Ed; 2012; 23(9):1129-51. PubMed ID: 21639993
[TBL] [Abstract][Full Text] [Related]
17. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies.
Jordan F; Naylor A; Kelly CA; Howdle SM; Lewis A; Illum L
J Control Release; 2010 Jan; 141(2):153-60. PubMed ID: 19772878
[TBL] [Abstract][Full Text] [Related]
18. Sustained delivery of human growth hormone using a polyelectrolyte complex-loaded thermosensitive polyphosphazene hydrogel.
Park MR; Chun C; Ahn SW; Ki MH; Cho CS; Song SC
J Control Release; 2010 Nov; 147(3):359-67. PubMed ID: 20713099
[TBL] [Abstract][Full Text] [Related]
19. Preparation of Eudragit E100 microspheres by modified solvent evaporation method.
Singh V; Chaudhary AK
Acta Pol Pharm; 2011; 68(6):975-80. PubMed ID: 22125964
[TBL] [Abstract][Full Text] [Related]
20. Single processing step toward injectable sustained-release formulations of Triptorelin based on a novel degradable semi-solid polymer.
Asmus LR; Kaufmann B; Melander L; Weiss T; Schwach G; Gurny R; Möller M
Eur J Pharm Biopharm; 2012 Aug; 81(3):591-9. PubMed ID: 22561956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
